# SODIUM BITARTRATE

URL: https://app.greenveil.ai/ingredients/ingredient_unii_75_e63_i9_h07
Categories: pharma
Identifier: cfr:21 CFR 331.11

> SODIUM BITARTRATE. Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 306 mg Assessed from 4 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 306 mg

## Regulatory status

- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 306 mg
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.

_Assessed by Greenveil._